Search

Home > OIS Podcast > EyeGate Finds New Paths to Dollars, Deal
Podcast: OIS Podcast
Episode:

EyeGate Finds New Paths to Dollars, Deal
Category: Business
Duration: 00:19:32
Publish Date: 2016-02-10 23:00:00
Description: EyeGate Pharmaceuticals had hit a wall. Its venture investors were tapped out, and the compa-ny needed capital to continue running clinical trials on its lead product. CEO Stephen From turned to the public markets, leading the company through a unique – and small IPO. With $4 million from the offering, the company signed an agreement with Valeant Pharmaceuticals Inc. to help fund the trial. The partnership enabled the company to raise another $10 million from investors, putting it on track to start a confirmatory Phase III clinical trial.
Total Play: 0